← All trials
NCT04965181
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2021
- Primary completion
- Apr 30, 2024
- Completion date
- Apr 30, 2024
- First posted
- Jul 16, 2021
- Last posted
- Jul 16, 2021
- Enrollment
- 485
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Georgia State UniversityLead sponsor
- National Cancer Institute (NCI)Collaborator
- Georgia State UniversityOverall official - principal investigator
- Georgia State UniversityReponsible party - principal investigator
- University of ChicagoCollaborator
- University of UtahCollaborator
- George Washington UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.